Did Trump pull research funds for cancer?
Multiple major outlets report that the Trump administration enacted policies and budget proposals in 2025–2026 that reduced or threatened federal cancer-research funding — including proposals to cut t...
Your fact-checks will appear here
US research institute, part of National Institutes of Health
Multiple major outlets report that the Trump administration enacted policies and budget proposals in 2025–2026 that reduced or threatened federal cancer-research funding — including proposals to cut t...
A comprehensive review of the available reporting shows no completed randomized, placebo‑controlled trials that prove ivermectin or mebendazole are effective cancer therapies; the literature instead c...
The ’s budget proposals and policy actions sought large reductions in funding—including a $1 billion hit to the in early proposals—and instituted grant pauses, indirect-cost caps, and program restrict...
Major health authorities and recent journalism say there is no proven link between Bluetooth headphones and cancer; Bluetooth devices emit very low-power, non‑ionizing radiofrequency radiation (RFR), ...
Funding changes under the Trump administration included freezes, cancellations and proposed formula changes that advisers and researchers say removed or delayed “hundreds of millions” in cancer-relate...
Receptive anal intercourse is repeatedly identified in major medical reviews and public-health organizations as a behavior associated with increased risk of anal cancer because it raises exposure to o...
Federal reporting and advocacy documents say the Trump administration targeted hundreds to thousands of federally funded research awards, including cancer grants: reporting cites about $1–2.3 billion ...
The U.S. recorded several distinct waves of COVID-19 deaths: roughly 384,536 deaths in 2020 and about 462,193 in 2021 according to year-by‑year counts drawn from CDC/MMWR compilations cited by Statist...
Two registered early‑phase clinical trials combine ivermectin with immune checkpoint inhibitors for cancer: a phase I/II investigator‑initiated trial testing oral ivermectin with balstilimab (and an e...
The Trump administration’s early 2025 budget actions and policy changes led to large, specific reductions and program shifts at NIH and the National Cancer Institute (NCI): reporting and committee ana...
Available reporting shows multiple actions by the Trump administration and Congressional maneuvers in 2024–2025 that critics say reduced federal support for pediatric cancer research — including propo...
The claim that COVID-19 vaccines cause a new entity called “turbo cancer” is not supported by the bulk of scientific and public‑health reporting: major cancer organizations and multiple fact‑checks sa...
The claim that specific cancer research programs were “reduced or eliminated under Trump’s budget” is rooted in multiple reporting threads: a proposed 2026 federal budget that would cut the NIH by rou...
Randomized trial evidence most clearly links supplemental vitamin E and selenium to increased prostate cancer risk in certain groups, based on the large Selenium and Vitamin E Cancer Prevention Trial ...
After radical prostatectomy, major guidelines and expert bodies expect PSA to fall to undetectable levels within weeks to a few months and use low numerical thresholds and serial rises to define bioch...
Large cohort studies and reviews link long‑term consumption of aspartame and acesulfame‑K to small but measurable increases in some cancer and cardiovascular risks, and experimental work suggests effe...
Sweet & Low and similar have been extensively studied with mixed findings: recent cohort and mechanistic studies link some low‑ and no‑calorie sweeteners to metabolic, cognitive, gut‑microbiota, and c...
ional appropriations for FY2026 rejected the ’s sweeping 40% cut and reorganization plan for — instead preserving the agency’s structure and delivering modest increases to NIH and funding compared wit...
The Trump administration’s interventions at NIH led to the termination or freezing of hundreds to thousands of awards covering a wide swath of biomedical research, including cancer studies; independen...
No completed human studies specifically reporting the safety or pharmacokinetics (PK) of high‑dose ivermectin in cancer patients have been published in the sources provided; the literature instead con...